Centre Léon-Bérard, 28 rue Laennec, Lyon, France.
Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Apr;129(2):111-4. doi: 10.1016/j.anorl.2011.02.014. Epub 2011 Jun 22.
To review treatment options in a rare type of parotid tumor, in a clinical case study.
A 62-year-old woman presenting with recurrence of acinic cell carcinoma of the parotid gland with invasion of the skull base was treated by external 3D conformational radiation, having refused large-scale exeresis. Sixty-six Gy (70Gy equivalent) were delivered in 2007. Clinical and paraclinical follow-up found regular tumor volume regression over a 2.5-year period without side-effects of radiation.
There are no specific data on the efficacy of external radiation therapy in acinic cell carcinoma; reports on exclusive radiation treatment of salivary gland cancer include different histological types. Exclusive radiation treatment should be at least 66-70Gy, preferably by neutron- or hadrontherapy.
Management of acinic cell carcinoma of the parotid is surgical with possible secondary radiation therapy; exclusive external radiation therapy is, however, an option in case of contra-indication for surgery or patient refusal.
通过临床病例研究,回顾一种罕见腮腺肿瘤的治疗选择。
一名 62 岁女性因腮腺的腺泡细胞癌复发且侵犯颅底而就诊,该患者拒绝了大范围切除术,故接受了外部三维适形放疗。2007 年,该患者接受了 66Gy(70Gy 等效剂量)的照射。经过 2.5 年的临床和影像学随访,发现肿瘤体积有规律地缩小,且没有放射治疗的副作用。
关于腺泡细胞癌的外部放射治疗疗效尚无具体数据;关于单纯放疗治疗唾液腺癌的报道包括不同的组织学类型。单纯放疗治疗应至少给予 66-70Gy,最好采用中微子或强子放疗。
腮腺的腺泡细胞癌的治疗方法是手术联合可能的辅助放疗;但如果手术禁忌或患者拒绝,单纯外部放疗也是一种选择。